Severe Asthma
Respiratory
Severe Asthma is treated with 2 medications in our database, including TEZSPIRE, XOLAIR, Xolair PFS, Xolair. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Amgen and AstraZeneca, Genentech. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Severe Asthma treatment below.
What help exists for Severe Asthma
7
drugs indexed
3
with copay cards
3
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Severe Asthma
7 totalDupixent
Dupilumab · Sanofi
🎟💙XOLAIR, Xolair PFS, Xolair
Genentech
CINQAIR
Reslizumab · Teva
FASENRA
Benralizumab
Nucala
mepolizumab · GlaxoSmithKline
🎟💙Exdensur
depemokimab
🎟💙TEZSPIRE
tezepelumab-ekko · Amgen and AstraZeneca
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Severe Asthma drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | Yes | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |